Software Healthcare Sector

Tetratherix

Market Cap: AU$328.8m

Engages in biomaterial and regenerative medicine business in Australia and internationally.

TerrAscend

Market Cap: CA$324.2m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Acme United

Market Cap: US$233.7m

Supplies cutting, measuring, first aid, and sharpening products to the school, home, office, hardware, sporting goods, and industrial markets in the United States, Canada, Europe, and internationally.

Organogenesis Holdings

Market Cap: US$231.6m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

NovaBridge Biosciences

Market Cap: US$231.3m

A biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States.

Minerva Neurosciences

Market Cap: US$231.1m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.

Neuronetics

Market Cap: US$228.6m

Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

Acumen Pharmaceuticals

Market Cap: US$228.5m

A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.

Utah Medical Products

Market Cap: US$227.8m

Offers medical devices for the healthcare industry in the United States, Europe, and internationally.

Protara Therapeutics

Market Cap: US$227.5m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Atrium Therapeutics

Market Cap: US$225.8m

A biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies.

Immunic

Market Cap: US$225.1m

A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.

Vitrafy Life Sciences

Market Cap: AU$307.1m

Engages in the research, development, and commercialization of cryopreservation solutions in Australia.

Coherus Oncology

Market Cap: US$219.4m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

AN2 Therapeutics

Market Cap: US$219.2m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

Cardiol Therapeutics

Market Cap: CA$301.4m

A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Journey Medical

Market Cap: US$218.7m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Keros Therapeutics

Market Cap: US$218.7m

A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

SIGA Technologies

Market Cap: US$218.4m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

PepGen

Market Cap: US$217.5m

A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.

High Tide

Market Cap: CA$297.0m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Tonix Pharmaceuticals Holding

Market Cap: US$215.2m

A fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States.

Alpha Cognition

Market Cap: US$212.3m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

Comjoyful International

Market Cap: US$211.5m

Operates and manages healthcare clubs in China.

Pro-Dex

Market Cap: US$209.7m

Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.

Voyager Therapeutics

Market Cap: US$208.9m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

Monash IVF Group

Market Cap: AU$290.3m

Engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia.

Satellos Bioscience

Market Cap: CA$286.6m

A clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.

Vector Science and Therapeutics

Market Cap: CA$286.1m

Develops and sells novel biomechanical devices and active localized drug-delivery platforms.

American Well

Market Cap: US$202.4m

An enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.

Corbus Pharmaceuticals Holdings

Market Cap: US$200.8m

A clinical stage company, develops and commercializes therapeutics for cancer and obesity.

Oramed Pharmaceuticals

Market Cap: US$200.1m

Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.

NervGen Pharma

Market Cap: US$200.0m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

AirSculpt Technologies

Market Cap: US$197.5m

Focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada.

AOTI

Market Cap: UK£143.6m

AOTI, Inc., together with its subsidiaries, patents, manufacturers, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide.

Korro Bio

Market Cap: US$194.1m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.